NASDAQ:BLAC Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free BLAC Stock Alerts $10.80 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$10.80▼$10.8050-Day Range$10.64▼$10.9152-Week Range$10.17▼$11.60Volume1 shsAverage Volume28,086 shsMarket Capitalization$60.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Get Bellevue Life Sciences Acquisition alerts: Email Address Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. About Bellevue Life Sciences AcquisitionBellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Read More BLAC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BLAC Stock News HeadlinesMay 13, 2024 | prnewswire.comBellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder MeetingMay 12, 2024 | americanbankingnews.comBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest UpdateApril 21, 2023 | wsj.comBellevue Life Sciences Acquisition Corp.April 18, 2023 | seekingalpha.comBLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928See More Headlines Receive BLAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:BLAC CUSIPN/A CIK1840425 Webwww.bellevuespac.com Phone425-635-7700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,620,000Free Float4,740,000Market Cap$60.70 million OptionableNot Optionable Beta-0.03 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Kuk Hyoun Hwang (Age 47)CEO & Director Mr. David Jin Yoo (Age 50)Chief Financial Officer Key CompetitorsCorner Growth Acquisition Corp. 2NASDAQ:TRONInception Growth AcquisitionNASDAQ:IGTANewbury Street AcquisitionNASDAQ:NBSTJVSPAC AcquisitionNASDAQ:JVSAHHG CapitalNASDAQ:HHGCView All CompetitorsInstitutional OwnershipBerkley W R CorpBought 322,690 shares on 5/16/2024Ownership: 5.742%K2 Principal Fund L.P.Bought 33,589 shares on 5/14/2024Ownership: 0.598%Wealthspring Capital LLCSold 32,684 shares on 4/18/2024Ownership: 0.606%View All Institutional Transactions BLAC Stock Analysis - Frequently Asked Questions How have BLAC shares performed in 2024? Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the beginning of the year. Since then, BLAC shares have increased by 2.9% and is now trading at $10.80. View the best growth stocks for 2024 here. Who are Bellevue Life Sciences Acquisition's major shareholders? Bellevue Life Sciences Acquisition's stock is owned by many different retail and institutional investors. Top institutional shareholders include Berkley W R Corp (5.74%), Wealthspring Capital LLC (0.61%) and K2 Principal Fund L.P. (0.60%). How do I buy shares of Bellevue Life Sciences Acquisition? Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BLAC) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.